May 17, 2018 — The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive…Original Article
FDA Approves Aimovig (erenumab-aooe) as a Preventive Treatment for Migraine
